Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natalie Ives

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
JAMA Pediatrics|December 20, 2021
Evaluation of Daily Low-Dose Prednisolone During Upper Respiratory Tract Infection to Prevent Relapse in Children With Relapsing Steroid-Sensitive Nephrotic Syndrome: The PREDNOS 2 Randomized Clinical TrialMartin T Christian, Nicholas J A Webb, Samir Mehta, et al.
Health Technology Assessment (Winchester, England)|January 21, 2022
Daily low-dose prednisolone to prevent relapse of steroid-sensitive nephrotic syndrome in children with an upper respiratory tract infection: PREDNOS2 RCTMartin T Christian, Nicholas Ja Webb, Rebecca L Woolley, et al.
Pilot and Feasibility Studies|March 18, 2023
Snacktivity™ to promote physical activity and reduce future risk of disease in the population: protocol for a feasibility randomised controlled trial and nested qualitative studyAmanda J Daley, Ryan A Griffin, Catherine A Moakes, et al.
Health and Social Care Delivery Research|August 28, 2024
Health screening clinic to reduce absenteeism and presenteeism among NHS Staff: eTHOS a pilot RCTRachel Adams, Rachel E Jordan, Alisha Maher, et al.
International Journal of Behavioral Medicine|February 24, 2025
Snacktivity™ to Promote Physical Activity in Primary Care, Community Health and Public Health Settings: A Feasibility Randomised Controlled TrialAmanda J Daley, Ryan A Griffin, James P Sanders, et al.
American Heart Journal|September 11, 2017
A randomized, multicenter, open-label, blinded end point trial comparing the effects of spironolactone to chlorthalidone on left ventricular mass in patients with early-stage chronic kidney disease: Rationale and design of the SPIRO-CKD trialManvir K Hayer, Nicola C Edwards, Gemma Slinn, et al.
Brain Communications|September 21, 2020
11β-Hydroxysteroid dehydrogenase type 1 inhibition in idiopathic intracranial hypertension: a double-blind randomized controlled trialKeira Markey, James Mitchell, Hannah Botfield, et al.
Trials|December 28, 2025
The effectiveness and cost effectiveness of Snacktivity™ as an intervention to promote physical activity and health outcomes: a study protocol for a multi-centre randomised controlled trialAmanda J Daley, Ryan A Griffin, James P Sanders, et al.
Trials|September 2, 2025
"SPHERE" multi-component novel psychosocial intervention for people with HIV: study protocol for a randomised controlled trialVasiliki Papageorgiou, Fiona C Lampe, Janey Sewell, et al.
Health Technology Assessment (Winchester, England)|September 26, 2022
Plasma exchange and glucocorticoids to delay death or end-stage renal disease in anti-neutrophil cytoplasm antibody-associated vasculitis: PEXIVAS non-inferiority factorial RCTDavid Jayne, Michael Walsh, Peter A Merkel, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
JAMA Pediatrics|December 20, 2021
Evaluation of Daily Low-Dose Prednisolone During Upper Respiratory Tract Infection to Prevent Relapse in Children With Relapsing Steroid-Sensitive Nephrotic Syndrome: The PREDNOS 2 Randomized Clinical TrialMartin T Christian, Nicholas J A Webb, Samir Mehta, et al.
Health Technology Assessment (Winchester, England)|January 21, 2022
Daily low-dose prednisolone to prevent relapse of steroid-sensitive nephrotic syndrome in children with an upper respiratory tract infection: PREDNOS2 RCTMartin T Christian, Nicholas Ja Webb, Rebecca L Woolley, et al.
Pilot and Feasibility Studies|March 18, 2023
Snacktivity™ to promote physical activity and reduce future risk of disease in the population: protocol for a feasibility randomised controlled trial and nested qualitative studyAmanda J Daley, Ryan A Griffin, Catherine A Moakes, et al.
Health and Social Care Delivery Research|August 28, 2024
Health screening clinic to reduce absenteeism and presenteeism among NHS Staff: eTHOS a pilot RCTRachel Adams, Rachel E Jordan, Alisha Maher, et al.
International Journal of Behavioral Medicine|February 24, 2025
Snacktivity™ to Promote Physical Activity in Primary Care, Community Health and Public Health Settings: A Feasibility Randomised Controlled TrialAmanda J Daley, Ryan A Griffin, James P Sanders, et al.
American Heart Journal|September 11, 2017
A randomized, multicenter, open-label, blinded end point trial comparing the effects of spironolactone to chlorthalidone on left ventricular mass in patients with early-stage chronic kidney disease: Rationale and design of the SPIRO-CKD trialManvir K Hayer, Nicola C Edwards, Gemma Slinn, et al.
Brain Communications|September 21, 2020
11β-Hydroxysteroid dehydrogenase type 1 inhibition in idiopathic intracranial hypertension: a double-blind randomized controlled trialKeira Markey, James Mitchell, Hannah Botfield, et al.
Trials|December 28, 2025
The effectiveness and cost effectiveness of Snacktivity™ as an intervention to promote physical activity and health outcomes: a study protocol for a multi-centre randomised controlled trialAmanda J Daley, Ryan A Griffin, James P Sanders, et al.
Trials|September 2, 2025
"SPHERE" multi-component novel psychosocial intervention for people with HIV: study protocol for a randomised controlled trialVasiliki Papageorgiou, Fiona C Lampe, Janey Sewell, et al.
Health Technology Assessment (Winchester, England)|September 26, 2022
Plasma exchange and glucocorticoids to delay death or end-stage renal disease in anti-neutrophil cytoplasm antibody-associated vasculitis: PEXIVAS non-inferiority factorial RCTDavid Jayne, Michael Walsh, Peter A Merkel, et al.
Pageof 9